ScoreWhy is Getein Biotech, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.09% and Operating profit at -16.44% over the last 5 years
2
The company has declared Negative results for the last 10 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 437.84 MM
- NET SALES(9M) At CNY 751.27 MM has Grown at -13.59%
- OPERATING PROFIT(Q) Lowest at CNY 33.29 MM
3
With ROE of 6.40%, it has a very attractive valuation with a 1.51 Price to Book Value
- Over the past year, while the stock has generated a return of -2.93%, its profits have fallen by -32.8%
- At the current price, the company has a high dividend yield of 2.3
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -2.93% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Getein Biotech, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Getein Biotech, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Getein Biotech, Inc.
13.27%
-0.13
21.12%
China Shanghai Composite
16.01%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.09%
EBIT Growth (5y)
-16.44%
EBIT to Interest (avg)
25.02
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.38
Tax Ratio
7.24%
Dividend Payout Ratio
40.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.03%
ROE (avg)
14.75%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
1.51
EV to EBIT
22.03
EV to EBITDA
13.24
EV to Capital Employed
1.80
EV to Sales
2.94
PEG Ratio
NA
Dividend Yield
2.25%
ROCE (Latest)
8.19%
ROE (Latest)
6.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -7.09% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -18.92 %
INVENTORY TURNOVER RATIO(HY)
Highest at 1.92 times
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 437.84 MM
NET SALES(9M)
At CNY 751.27 MM has Grown at -13.59%
OPERATING PROFIT(Q)
Lowest at CNY 33.29 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 13.59 %
Here's what is working for Getein Biotech, Inc.
Debt-Equity Ratio
Lowest at -18.92 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 1.92 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -7.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Getein Biotech, Inc.
Net Sales
At CNY 751.27 MM has Grown at -13.59%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 437.84 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit
Lowest at CNY 33.29 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 13.59 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
